Bionano Genomics, Inc. BNGO will release earnings results for its fourth quarter, after the closing bell on Monday, March 23.
Genomics has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 39.8% and now trades at $18.24. This was partly thanks to its solid quarterly ...
The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected the UG200 Series as the ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
Living with a rare disease often means years of uncertainty, misdiagnosis, and limited treatment options. But advances in ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest Diagnostics, a leading provider of diagnostic information services, to ...
We are now entering the third decade of the 21st Century, and, especially in the last years, the achievements made by scientists have been exceptional, ...
Basecamp Research has launched a new scientific initiative, called the Trillion Gene Atlas, to bring together genomic data ...
Investor's Business Daily on MSN
10x Genomics shows market leadership with jump to 92 RS rating
10x Genomics sees its Relative Strength Rating enter the elite 90-plus level.
Neogen Corp. in Lansing, a leader in food safety solutions, has entered into a definitive agreement to sell its global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results